TCWM
NVO

Total Clarity Wealth Management’s Novo Nordisk NVO Stock Holding History

Total Clarity Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-408
Closed -$23K – 728
2022
Q2 		$23K Buy
+408
New +$22.6K 0.01% 528
2022
Q1 		– Sell
-408
Closed -$23K – 672
2021
Q4 		$23K Buy
408
+90
+28% +$4.88K 0.01% 542
2021
Q3 		$15K Buy
+318
New +$15.4K 0.01% 603

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Total Clarity Wealth Management's NVO Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 408 shares — an estimated $23K sold.

Total Clarity Wealth Management first reported a position in NVO in Q3 2021 and held it in 3 quarters. The position peaked at $23K in Q2 2022. 907 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 408 Novo Nordisk shares in Q3 2022, an estimated $23K.
  • Total Clarity Wealth Management first reported a position in Novo Nordisk in Q3 2021 and held it in 3 quarters.
  • Total Clarity Wealth Management's Novo Nordisk position peaked at $23K in Q2 2022.
  • 907 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.